Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Zloza

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Journal for Immunotherapy of Cancer|January 9, 2018
Viruses, bacteria, and parasites - oh my! a resurgence of interest in microbial-based therapy for cancerAndrew Zloza
Current Pharmacology Reports|December 5, 2017
Infection: a Cause of and Cure for CancerJenna H Newman, Andrew Zloza
Journal of Leukocyte Biology|December 29, 2005
Multiple populations of T lymphocytes are distinguished by the level of CD4 and CD8 coexpression and require individual considerationAndrew Zloza, Lena Al-Harthi
Nanomedicine (London, England)|November 4, 2017
Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancerCharles B Chesson, Andrew Zloza
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2018
Double-Humanized Mouse Model to Study Bone Morphogenetic Protein (BMP) Signaling in Tumor XenograftsJenna Newman, Rachel NeMoyer, Andrew Zloza, et al.
Frontiers in Oncology|March 13, 2024
Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironmentKajal H Gupta, Eileena F Giurini, Andrew Zloza
Nature Reviews. Drug Discovery|September 2, 2015
Oncolytic viruses: a new class of immunotherapy drugsHoward L Kaufman, Frederick J Kohlhapp, Andrew Zloza
Drug Discovery Today|November 11, 2015
IFN-lambda therapy: current status and future perspectivesAhmed Lasfar, Andrew Zloza, Karine A Cohen-Solal
Frontiers in Immunology|February 13, 2019
Immunobiochemical Reconstruction of Influenza Lung Infection-Melanoma Skin Cancer InteractionsEvgeni V Nikolaev, Andrew Zloza, Eduardo D Sontag
Nature Reviews. Drug Discovery|March 26, 2019
Oncolytic viruses: a new class of immunotherapy drugsHoward L Kaufman, Frederick J Kohlhapp, Andrew Zloza
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Journal for Immunotherapy of Cancer|January 9, 2018
Viruses, bacteria, and parasites - oh my! a resurgence of interest in microbial-based therapy for cancerAndrew Zloza
Current Pharmacology Reports|December 5, 2017
Infection: a Cause of and Cure for CancerJenna H Newman, Andrew Zloza
Journal of Leukocyte Biology|December 29, 2005
Multiple populations of T lymphocytes are distinguished by the level of CD4 and CD8 coexpression and require individual considerationAndrew Zloza, Lena Al-Harthi
Nanomedicine (London, England)|November 4, 2017
Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancerCharles B Chesson, Andrew Zloza
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2018
Double-Humanized Mouse Model to Study Bone Morphogenetic Protein (BMP) Signaling in Tumor XenograftsJenna Newman, Rachel NeMoyer, Andrew Zloza, et al.
Frontiers in Oncology|March 13, 2024
Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironmentKajal H Gupta, Eileena F Giurini, Andrew Zloza
Nature Reviews. Drug Discovery|September 2, 2015
Oncolytic viruses: a new class of immunotherapy drugsHoward L Kaufman, Frederick J Kohlhapp, Andrew Zloza
Drug Discovery Today|November 11, 2015
IFN-lambda therapy: current status and future perspectivesAhmed Lasfar, Andrew Zloza, Karine A Cohen-Solal
Frontiers in Immunology|February 13, 2019
Immunobiochemical Reconstruction of Influenza Lung Infection-Melanoma Skin Cancer InteractionsEvgeni V Nikolaev, Andrew Zloza, Eduardo D Sontag
Nature Reviews. Drug Discovery|March 26, 2019
Oncolytic viruses: a new class of immunotherapy drugsHoward L Kaufman, Frederick J Kohlhapp, Andrew Zloza
Pageof 8